Solidus Investment

Developer of an on-demand matching platform designed to connect service providers with customers. The company's platform uses algorithms and on-demand experience to match customers' needs with service areas such as professional moving, cleaning, mortgage, and education, enabling service providers to increase their visibility and expand their client base.

ORUM THERAPEUTICS, INC. engages in the research and development of therapeutic antibodies using cell penetrating antibody platform. Its platform targets specific cell types and adapts to different cell types and different intracellular proteins without chemical modifications. The company develops products for treatment of genetic diseases and cancer. ORUM THERAPEUTICS, INC. was founded in 2016 and is based in Daejeon, South Korea.

ORUM THERAPEUTICS, INC. engages in the research and development of therapeutic antibodies using cell penetrating antibody platform. Its platform targets specific cell types and adapts to different cell types and different intracellular proteins without chemical modifications. The company develops products for treatment of genetic diseases and cancer. ORUM THERAPEUTICS, INC. was founded in 2016 and is based in Daejeon, South Korea.

essys is a Manufacturing and sales of automotive IT parts.

Purunagun Distribution is a Manufacture and distribution of ice cream with domestic agricultural products.

AnyGen Co., Ltd. is a bio-venture company based in Gwangju, South Korea, established in 2000. It specializes in the manufacture of peptide APIs and drug development, offering a range of services, including GMP, generic, custom, and catalog peptides. The company is actively developing several drug candidates, including AGM-130 for breast cancer, AGM-212 for type 2 diabetes, AGM-251 for neuropathic pain, and AGM-290 for MRSA infections. As the first bio-venture company in the Gwangju and Jeonnam regions, AnyGen has localized peptide biomaterials that were previously reliant on imports, ensuring high quality and competitive pricing. The company was listed on the KOSDAQ market in 2016, reflecting its advancements in peptide biomaterials and new drug development technology, thus contributing to the stabilization of peptide drug raw material prices and promoting public health.

Techcross is a Ballast Water Treatment Facility.

Cheongwoo Food is a Comprehensive Confectionery.

Vitrosys Inc. is a bio-engineering company based in Yeongju, South Korea, founded in 2002. The company specializes in the production of plant-based medicines, focusing on creating complete medicinal products from single cells or tissues. Vitrosys offers a range of products, including cultured roots of Korean mountain ginseng and various extracts, such as nano powder and beverages made from these roots. Additionally, the company provides natural materials, bio reactors, and health food, alongside services for plant cloning and research outsourcing. Its operations emphasize the extraction and analysis of natural metabolites that exhibit physiological benefits, thereby enabling the consumption of natural drugs.

Genomictree Inc. is a company based out of South Korea.

Alteogen Inc. is a biotechnology company founded in 2008 and headquartered in Daejeon, South Korea, specializing in the development of long-acting biobetters, antibody-drug conjugates, and antibody biosimilars. The company is advancing several notable projects, including ALT-P1, a long-acting human growth hormone currently in Phase IIa clinical trials, and ALT-Q2, a long-acting coagulation factor VII for hemophilia, utilizing its NexP technology. Additionally, Alteogen is developing ALT-P7, a targeted treatment for breast and gastric cancer in Phase I trials, and ALT-Q5, an antibody-drug conjugate for ovarian cancer based on its NexMab technology. The company has formed strategic alliances with Kissei Pharmaceutical for Aflibercept, which has completed pre-clinical trials, and with Cristalia for Trastuzumab, which is in Phase II trials for breast cancer treatment. Through its innovative technologies, including NexP Fusion Technology and NexMab ADC Technology, Alteogen aims to enhance the efficacy and comparability of biologics in the market.

IDAL SYSTEM is a Smart RPC Management System.

Novarex Co., Ltd. is a South Korean company that develops and produces health functional foods and raw materials for both domestic and international markets. Established in 2008 and headquartered in Cheongju, Novarex specializes in a diverse range of dietary supplements, including lactic acid bacteria, probiotics, omega-3 products, vitamins, and minerals. The company also provides functional foods targeting eye health, diet, pregnancy, children's nutrition, and prostate health. Its products are available in various forms such as tablets, soft and hard capsules, powders, gummies, and stick jellies. Previously known as Health Science Co., Ltd., the company rebranded to Novarex in November 2013.

Maniker F&G Co., Ltd. produces, processes, and sells frozen, chilled, and retorted food products. It offers a range of chicken and beef products for home and business use. The company also exports its products to the United States. Maniker F&G Co., Ltd. was founded in 1993 and is headquartered in Yongin, South Korea.

BioLeaders Corporation is a healthcare company based in Yongin, South Korea, specializing in medicine and consumer products. Established in 1999, the company develops innovative therapies, including P53, a targeted anti-cancer drug. Its clinical pipeline features BLS-H01, currently in phase 3 trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same indication. Additionally, BioLeaders is advancing BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, an adjuvant for vaccines. Beyond pharmaceuticals, the company also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a significant player in both the medical and consumer health sectors.

Kookdae F & B is a franchise business.